Easton Pharmaceutica Financials
Based on the key measurements obtained from Easton Pharmaceutica's financial statements, Easton Pharmaceutica is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. As of now, Easton Pharmaceutica's Other Current Assets are increasing as compared to previous years. The Easton Pharmaceutica's current Common Stock is estimated to increase to about 162.4 K, while Total Current Liabilities is projected to decrease to under 557.7 K. Key indicators impacting Easton Pharmaceutica's financial strength include:
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.33 | 0.62 |
|
|
The financial analysis of Easton Pharmaceutica is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Easton Pharmaceutica includes many different criteria found on its balance sheet. For example, investors should never minimize Easton Pharmaceutica's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Easton Pharmaceutica's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Easton Pharmaceutica.
Net Income |
|
With this module, you can analyze Easton financials for your investing period. You should be able to track the changes in Easton Pharmaceutica individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Easton | Select Account or Indicator |
Understanding current and past Easton Pharmaceutica Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Easton Pharmaceutica's financial statements are interrelated, with each one affecting the others. For example, an increase in Easton Pharmaceutica's assets may result in an increase in income on the income statement.
The data published in Easton Pharmaceutica's official financial statements usually reflect Easton Pharmaceutica's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Easton Pharmaceutica. For example, before you start analyzing numbers published by Easton accountants, it's critical to develop an understanding of what Easton Pharmaceutica's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Easton Pharmaceutica's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Easton Pharmaceutica's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Easton Pharmaceutica's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Easton Pharmaceutica. Please utilize our Beneish M Score to check the likelihood of Easton Pharmaceutica's management manipulating its earnings.
Easton Pharmaceutica Stock Summary
Easton Pharmaceutica competes with Alkermes Plc, Ironwood Pharmaceuticals, Deciphera Pharmaceuticals, Eagle Pharmaceuticals, and Neurocrine Biosciences. Parallel Industries Inc. does not have significant operations. Parallel Industries Inc. was founded in 1997 and is headquartered in Toronto, Canada. Easton Pharmaceuticals is traded on OTC Exchange in the United States.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | OTCCE Exchange |
| ISIN | US2777741057 |
| Business Address | 111 Brockhouse Road, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.eastonpharma.com |
| Phone | 647 362 5700 |
| Currency | USD - US Dollar |
You should never invest in Easton Pharmaceutica without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Easton Stock, because this is throwing your money away. Analyzing the key information contained in Easton Pharmaceutica's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Easton Pharmaceutica Key Financial Ratios
Generally speaking, Easton Pharmaceutica's financial ratios allow both analysts and investors to convert raw data from Easton Pharmaceutica's financial statements into concise, actionable information that can be used to evaluate the performance of Easton Pharmaceutica over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Easton Pharmaceutica reports annually and quarterly.| Return On Equity | -0.0269 | ||||
| Price To Sales | 0.06 X | ||||
| Gross Profit | 201.4 K |
Easton Pharmaceutica Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 2.6M | 10.1M | 17.2M | 10.2M | 11.7M | 12.3M | |
| Other Liab | 48.3K | 46.2K | 161.1K | 180.2K | 162.1K | 250.1K | |
| Accounts Payable | 30.8K | 568.5K | 845.1K | 255.8K | 230.2K | 327.4K | |
| Total Liab | 2.5M | 3.0M | 10.1M | 3.3M | 3.8M | 2.0M | |
| Other Assets | 1.8M | 742.6K | 95.8K | 94.0K | 84.6K | 80.4K | |
| Net Tangible Assets | (465.0K) | (1.1M) | (1.1M) | (1.0M) | (930.6K) | (884.0K) | |
| Retained Earnings | (39.1M) | (39.2M) | (39.6M) | (39.8M) | (35.8M) | (37.6M) | |
| Long Term Debt | 2.2M | 2.2M | 8.5M | 2.5M | 2.9M | 1.9M | |
| Total Current Assets | 198K | 66.3K | 249.8K | 426.3K | 383.7K | 234.0K |
Easton Pharmaceutica Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Easton Pharmaceutica's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Operating Income | 54.9K | (124.2K) | (323.2K) | (188.5K) | (216.8K) | (227.7K) | |
| Ebit | (245.3K) | (124.2K) | (323.2K) | (188.5K) | (216.8K) | (227.7K) | |
| Income Before Tax | (245.3K) | (169.2K) | (323.2K) | (188.5K) | (216.8K) | (227.7K) | |
| Net Income | (245.3K) | (169.2K) | (323.2K) | (188.5K) | (216.8K) | (227.7K) |
Easton Pharmaceutica Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Easton Pharmaceutica. It measures of how well Easton is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Easton Pharmaceutica brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Easton had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Easton Pharmaceutica has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (43.0) | 156.8K | 493.0K | 258K | 296.7K | 311.5K | |
| Net Income | (245.3K) | (169.2K) | (323.2K) | (188.5K) | (216.8K) | (227.7K) | |
| Change To Netincome | 10.9M | 163.2K | 434.5K | (267.8K) | (308.0K) | (292.6K) |
Easton Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Easton Pharmaceutica's current stock value. Our valuation model uses many indicators to compare Easton Pharmaceutica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Easton Pharmaceutica competition to find correlations between indicators driving Easton Pharmaceutica's intrinsic value. More Info.Easton Pharmaceutica is rated # 5 in return on equity category among related companies. It is rated # 5 in return on asset category among related companies . As of now, Easton Pharmaceutica's Return On Equity is decreasing as compared to previous years.Comparative valuation analysis is a catch-all model that can be used if you cannot value Easton Pharmaceutica by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Easton Pharmaceutica's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Easton Pharmaceutica's earnings, one of the primary drivers of an investment's value.Easton Pharmaceutica Systematic Risk
Easton Pharmaceutica's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Easton Pharmaceutica volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Easton Pharmaceutica correlated with the market. If Beta is less than 0 Easton Pharmaceutica generally moves in the opposite direction as compared to the market. If Easton Pharmaceutica Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Easton Pharmaceutica is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Easton Pharmaceutica is generally in the same direction as the market. If Beta > 1 Easton Pharmaceutica moves generally in the same direction as, but more than the movement of the benchmark.
About Easton Pharmaceutica Financials
What exactly are Easton Pharmaceutica Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Easton Pharmaceutica's income statement, its balance sheet, and the statement of cash flows. Potential Easton Pharmaceutica investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Easton Pharmaceutica investors may use each financial statement separately, they are all related. The changes in Easton Pharmaceutica's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Easton Pharmaceutica's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Easton Pharmaceutica Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Easton Pharmaceutica is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Easton has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Easton Pharmaceutica's financials are consistent with your investment objective using the following steps:- Review Easton Pharmaceutica's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Easton Pharmaceutica's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Easton Pharmaceutica's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Easton Pharmaceutica's stock is overvalued or undervalued.
Today, most investors in Easton Pharmaceutica Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Easton Pharmaceutica's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Easton Pharmaceutica growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Easton Pharmaceutica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Easton Stock analysis
When running Easton Pharmaceutica's price analysis, check to measure Easton Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easton Pharmaceutica is operating at the current time. Most of Easton Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Easton Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easton Pharmaceutica's price. Additionally, you may evaluate how the addition of Easton Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Easton Pharmaceutica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.001 | Return On Assets (0.01) | Return On Equity (0.03) |
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.